Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124296076 | 12429607 | 6 | F | 201605 | 20160905 | 20160602 | 20160908 | EXP | US-BAYER-2016-052101 | BAYER | 27.00 | YR | A | F | Y | 45.35000 | KG | 20160908 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124296076 | 12429607 | 1 | PS | ADEMPAS | RIOCIGUAT | 1 | UNK | 204819 | |||||||||||
| 124296076 | 12429607 | 2 | SS | ADEMPAS | RIOCIGUAT | 1 | Oral | 2.5 MG, TID | BXH7CK3 | 204819 | 2.5 | MG | TID | ||||||
| 124296076 | 12429607 | 3 | SS | ADEMPAS | RIOCIGUAT | 1 | Oral | 2.5 MG, TID | BXH8FC1 | 204819 | 2.5 | MG | TID | ||||||
| 124296076 | 12429607 | 4 | SS | ADEMPAS | RIOCIGUAT | 1 | Oral | 2.5 MG, TID | BXH94K1 | 204819 | 2.5 | MG | TID | ||||||
| 124296076 | 12429607 | 5 | SS | REMODULIN | TREPROSTINIL | 1 | UNK | 0 | |||||||||||
| 124296076 | 12429607 | 6 | C | LETAIRIS | AMBRISENTAN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124296076 | 12429607 | 1 | Pulmonary arterial hypertension |
| 124296076 | 12429607 | 2 | Pulmonary arterial hypertension |
| 124296076 | 12429607 | 3 | Pulmonary arterial hypertension |
| 124296076 | 12429607 | 4 | Pulmonary arterial hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124296076 | 12429607 | HO |
| 124296076 | 12429607 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124296076 | 12429607 | Application site erythema | |
| 124296076 | 12429607 | Application site perspiration | |
| 124296076 | 12429607 | Application site pruritus | |
| 124296076 | 12429607 | Asthma | |
| 124296076 | 12429607 | Device related infection | |
| 124296076 | 12429607 | Emergency care | |
| 124296076 | 12429607 | Flatulence | |
| 124296076 | 12429607 | Hospitalisation | |
| 124296076 | 12429607 | Infusion site cellulitis | |
| 124296076 | 12429607 | Injection site pain | |
| 124296076 | 12429607 | Injection site reaction | |
| 124296076 | 12429607 | Sepsis | |
| 124296076 | 12429607 | Wheezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124296076 | 12429607 | 1 | 20150820 | 0 |